הזמנת תורים

050-6821277

פרסומים PUBLICATIONS

  1. H. Tabenkin, Y. Fogelman, R. Weiss, A. Tamir. Primary care consultation rates among the middle aged and elderly. Harefuah 1993; 124:121-3.(Hebrew)
  2. Y. Fogelman, H. Tabenkin, R. Weiss, A. Tamir. Characteristics of registered clinic patients who have not visited their family physician for 3 years. Family Practice 1993; 10:46-48.
  3. Y. Fogelman, Y. Rakover, R. Luboshitzky. High prevalence of Vitamin D Deficiency among Ethiopian Women immigrants to Israel- Exacerbation during pregnancy and lactation.ֹ Isr J Med Sci 1995; 31:221-224.
  4. Y. Fogelman.Variations in the use of Methylphenidate in Northern Israel. Isr J Fam Prac 1999; 9: 53-55.
  5. M. Schein, A. Biderman, M . Baras, L . Bennett, B. Bisharat, J. Borkan, Y. Fogelman, L. Gordon, D. Steinmetz, E. Kitai. The prevalence of a history of child sexual abuse among adults visiting family practitioners in Israel. Child Abuse Negl 2000; 24(5) :667-75.
  6. Y. Fogelman , E. Kahan Methylphenidate use for attention deficit hyperactivity disorder in northern Israel: a controversial issue. Isr Med Assoc J 2001;3(12): 925-7.
  7. L. Gercenshtein, Y. Fogelman, J Yaphe. Increasing the satisfaction of general practitioners with continuing medical education programs: A method for quality improvement through increasing teacher-learner interaction. BMC Family Practice 2002, 3:15
  8. Y Fogelman ,S Vinker,J Lachter , ABiderman, B Itzhak, E Kitai. Managing Obesity: A survey of attitudes and practices among Israeli primary care physicians. Int J Obes Relat Metab Disord. 2002 Oct;26(10):1393-7.
  9. R Weiss , Y Fogelman ,J Yaphe .Somatization in response to undiagnosed obsessive compulsive disorder in a family. : BMC Fam Pract 2003 Feb 20;4(1):1.
  10.  E Kahan, Y Fogelman , E Kitai ,S Vinker. Patient and Family Physician Preferences for  Care  and Communication in the Eventuality of Anthrax Terrorism .Fam Pract. 2003 Aug; 0(4): 441-2
  11. Y Fogelman , Vinker S, Guy N, Kahan E. Prevalence of and change in the prescription of    methylphenidate in Israel over a 2-year period. CNS Drugs. 2003;17(12):915-9.
  12. Vinker S, Y Fogelman, Elhayany A, Nakar S, Kahan E. Using electronic databases for the detection of unrecognized diabetic patients. Cardiovasc Diabetol. 2:13 2003 Nov 14
  13. Y Fogelman, , B Bloch, , E Kahan, Assessment of participation in physical activities and  relationship to socioeconomic and health factors; The controversial value of self- perception. Patient Educ Couns. 2004 Apr;53(1):95-9.
  14. Kahan E, Fogelman Y, Bloch B. Correlations of work, leisure, and sports physical
  15. activities and health status with socioeconomic factors: a national study in Israel.         Postgrad Med J. 2005 Apr;81(954):262-5.
  16. Kahan NR, Fogelman Y, Waitman DA, Kahan E, Bar-Yochai A, Meidan A, Kitai E.  Teaching evidence-based medicine in a managed care setting: from didactic exercise to pharmacopolicy development tool. Am J Manag Care. 2005 Sep;11(9):570-2.
  17. Carmeli E, Harpaz Y, Kogan NN, Fogelman Y. The effect of an endogenous antioxidant glabridin on oxidized LDL. J Basic Clin Physiol Pharmacol. 2008;19(1):49-63.
  18. Carmeli E, Fogelman Y. Antioxidant effect of polyphenolic glabridin on LDL oxidation.Toxicol Ind Health; 2009 May ;25(4-5):321-324